Jump to a section
Buy Tesamorelin peptide: vial or prefilled pen
10 mg of tesamorelin in either format: a powder vial or a prefilled 3 mL pen. The vial needs preparation. The pen already contains liquid at about 3.33 mg/mL. Both hold the same total amount of peptide. [1]
Online ordering is not available yet.
Tesamorelin 10 mg vial
Single-ingredient Tesamorelin powder. Final mixed volume determines the concentration.
- Form
- Freeze-dried powder
- Preparation
- Mixing required
- Sealed storage
- −20°C (−4°F) · dry · dark
- Mixed storage
- 2–8°C (36–46°F)
Batch COA pending.
Tesamorelin 10 mg prefilled pen
3 mL prefilled · approximately 3.33 mg/mL · no powder mixing.
- Volume
- 3 mL
- Concentration
- 10/3 ≈ 3.33 mg/mL
- Solution
- Water + 0.9% benzyl alcohol
- Storage
- 2–8°C (36–46°F) · no freezing
A volume-per-click setting has not been supplied.
Batch COA pending.
Research-labelled products. Drawings show the formats; they are not product photographs.
Tesamorelin 10 mg vial
A sealed glass vial containing 10 mg of freeze-dried tesamorelin. The powder stays dry until preparation, so the concentration can be set by the final liquid volume. The ingredient is tesamorelin alone; it is not a blend with ipamorelin or another growth-hormone peptide. [1]
More liquid makes each millilitre less concentrated; it does not add more tesamorelin. For example, a 1 mg amount occupies 0.2 mL at 5 mg/mL, or 0.3 mL at 3.33 mg/mL. Each calculation starts with the full 10 mg in the vial.
The preparation method still needs a compatible diluent and a supported mixing volume. Those product-specific instructions are not available for this vial. The figures above are concentration examples, not mixing directions borrowed from a different formulation.
10 mg vial preparation and concentration → · Target amount calculator →
Tesamorelin pen: 10 mg in 3 mL
The pen holds 10 mg of tesamorelin already dissolved in a 3 mL cartridge. Its concentration is 10 ÷ 3, or about 3.33 mg/mL. The liquid contains water and 0.9% benzyl alcohol. [1]
Already filled
No powder to dissolve or diluent to measure. The concentration is fixed when the cartridge is filled.
10 mg per pen
One pen contains the same nominal amount of tesamorelin as one 10 mg vial. The larger liquid volume is not extra peptide.
At this concentration, 1 mg corresponds to 0.3 mL. A pen dial setting needs a separate value: the amount of liquid delivered per click or marked increment. That calibration has not been provided, so cartridge size alone cannot supply a click count. Do not add water to the prefilled cartridge.
Vial and pen specifications
| Detail | 10 mg vial | 10 mg pen |
|---|---|---|
| Tesamorelin content | 10 mg | 10 mg |
| Format | Freeze-dried powder | Prefilled liquid cartridge |
| Liquid volume | Set during preparation | 3 mL |
| Concentration | 10 mg ÷ final volume | 10/3 mg/mL, about 3.33 |
| Preparation | Requires a specified diluent and mixing method | No reconstitution |
| Solution ingredients | Depend on the specified diluent | Water + 0.9% benzyl alcohol |
| Measurement | Volume calculated from the actual concentration | Fixed concentration; device calibration still required |
| Batch certificate | PDF not available | No finished-cartridge report available |
Copying a liquid volume between formats can change the amount of tesamorelin. For a vial prepared to 2 mL, a 0.2 mL volume contains 1 mg. The same 0.2 mL from the pen contains about 0.67 mg. Equal total content does not mean equal concentration.
These are research-labelled products. Prescription EGRIFTA is a separate formulation used for excess abdominal fat in adults with HIV-associated lipodystrophy. Its tested doses, preparation and storage instructions belong to that medicine. [2] Tesamorelin formulations and daily amounts →
Compare quantity and cost per milligram
Both formats contain 10 mg, so divide either price by 10 to compare nominal cost per milligram. At the same price, they provide equal peptide quantity. A higher pen price would pay for the prepared format and device, rather than a larger tesamorelin total.
Keep preparation supplies and unused material in the comparison. The vial requires a compatible diluent and measuring equipment; the pen arrives filled. Extra accessories, prices and ordering destinations have not been confirmed for these listings.
A 10 mg container represents ten 1 mg portions or five 2 mg portions mathematically. That arithmetic does not set a daily schedule, account for transfer or priming losses, or establish how long the prepared product remains usable. Course quantities and formulation differences →
Tesamorelin storage
−20°C / −4°F
Keep the vial dry and protected from light. Let it reach room temperature before opening to reduce moisture condensation.
2–8°C / 36–46°F
Protect from light. Keep the pen in its original carton and do not freeze it.
The product documents do not establish an after-mixing or after-opening lifespan. Refrigeration temperature and usable life are separate specifications. An expiry for sealed powder cannot become the expiry for a mixed vial, and EGRIFTA's storage instructions cannot be assigned to these products. [1]
Tesamorelin certificate of analysis
Original Tesamorelin COA pending
No batch-specific certificate has been supplied for these products. Purity, identity, vial content and finished-pen testing results will appear here when the original report is available.
No batch-specific purity, identity or content result is displayed without the source report. A safety data sheet describes handling; it does not contain the lot's analytical results. For the pen, a certificate for the starting peptide would also need to be distinguished from testing of the finished liquid cartridge.
Tesamorelin peptide guide → · Benefits and clinical results → · Side effects →
Questions & answers.
Does the Tesamorelin pen contain more than the vial?
No. Both contain 10 mg of tesamorelin. The pen holds that amount in 3 mL of liquid; the vial contains dry powder.
Does the prefilled pen need reconstitution?
No. Its solution is already prepared. Do not add water to the cartridge.
How many portions are in a 10 mg vial?
Divide 10 mg by the amount in each portion: 1 mg gives ten mathematical portions, while 2 mg gives five. Usable yield also depends on losses and the product’s discard limit.
Can I use the same liquid volume for the vial and pen?
Only if the concentrations match. A 10 mg vial prepared to 2 mL is 5 mg/mL; the 3 mL pen is about 3.33 mg/mL. The same volume therefore contains different peptide amounts.
Are needles and mixing supplies included?
The vial specification identifies a sealed powder vial. The pen specification describes a prefilled cartridge with a fitted needle. An additional needle pack, diluent and other accessories are not confirmed.
Is there a Tesamorelin COA to download?
A batch-specific Tesamorelin certificate has not been supplied or located. No purity percentage, batch identity result or finished-pen testing claim is shown in its place.
Can I order either product here now?
Online ordering is not available yet. Prices and checkout destinations have not been connected.